GAD2

GAD2

GAD2 Overview

Molecule Name
Glutamate decarboxylase 2
Synonyms
GAD2,GAD65,Glutamate decarboxylase 2
Drug Development Progress
Drugs in Clinical Trials1
Approved Drugs0
Highest Development StagePending
Target Synonym
EC 4.1.1.15,GAD65,Glutamate Decarboxylase 2 (Pancreatic Islets And Brain, 65kD),Glutamate Decarboxylase-2 (Pancreas),EC:4.1.1.15,EC 4.1.1,Glutamate decarboxylase 65 kDa isoform,65 kDa glutamic acid decarboxylase,GAD2,Glutamate Decarboxylase 2,Glutamate Decarboxylase 2 (Pancreatic Islets And Brain, 65kDa),GAD-65
Background
Glutamate decarboxylase or glutamic acid decarboxylase (GAD) is an enzyme that catalyzes the decarboxylation of glutamate to gamma-aminobutyric acid (GABA), the major inhibitory transmitter in higher brain regions, and putative paracrine hormone in pancreatic islets. GAD uses pyridoxal-phosphate (PLP) as a cofactor.Two molecular forms of GAD (65 kDa and 67 kDa) are highly conserved and both are expressed in the CNS, pancreatic islet cells, testis, oviduct and ovary. The isoforms are regionally distributed cytoplasmically in the brains of rats and mice. GAD65 is an ampiphilic, membrane-anchored protein (585 a.a.), and is responsible for vesicular GABA production. GAD67 is cytoplasmic (594 a.a.), and seems to be responsible for significant cytoplasmic GABA production.

GAD2 Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
KLS-2031KLS-2031Kolon Life Science. Inc
Details